Zydus Lifesciences reports positive topline from Evidences-X Phase II(B)
Zydus Lifesciences said its completed Evidences-X Phase II(B) clinical trial of saroglitazar Mg delivered positive topline results.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.